1. Impact of breath sampling on exhaled carbon monoxide
- Author
-
Ramin Ghorbani, Florian M. Schmidt, and Anders Blomberg
- Subjects
Pulmonary and Respiratory Medicine ,Adult ,Male ,Fysiologi ,Physiology ,Respiratory Medicine and Allergy ,Medical Laboratory and Measurements Technologies ,Analytical chemistry ,breath sampling ,Heme ,Nose ,Axial diffusion ,Specimen Handling ,chemistry.chemical_compound ,Diffusing capacity ,Humans ,laser absorption spectroscopy ,healthy non-smoker baseline ,Medicinsk laboratorie- och mätteknik ,Lungmedicin och allergi ,Carbon Monoxide ,Mouth ,Breath sampling ,Healthy subjects ,Exhalation ,carbon monoxide (CO) ,Weak correlation ,chemistry ,Breath Tests ,real-time breath gas analysis ,Breathing ,pulmonary gas exchange model ,Female ,Rheology ,Carbon monoxide - Abstract
The influence of breath sampling on exhaled carbon monoxide (eCO) and related pulmonary gas exchange parameters is investigated in a study with 32 healthy non-smokers. Mid-infrared tunable diode laser absorption spectroscopy and well-controlled online sampling is used to precisely measure mouth- and nose-exhaled CO expirograms at exhalation flow rates (EFRs) of 250, 120 and 60 ml s−1, and for 10 s of breath-holding followed by exhalation at 120 ml s−1. A trumpet model with axial diffusion is employed to fit simulated exhalation profiles to the experimental expirograms, which provides equilibrium airway and alveolar CO concentrations and the average lung diffusing capacity in addition to end-tidal concentrations. For all breathing maneuvers, excellent agreement is found between mouth- and nose-exhaled end-tidal CO (ETCO), and the individual values for ETCO and alveolar diffusing capacity are consistent across maneuvers. The eCO parameters clearly show a dependence on EFR, where the lung diffusing capacity increases with EFR, while ETCO slightly decreases. End-tidal CO is largely independent of ambient air CO and alveolar diffusing capacity. While airway CO is slightly higher than, and correlates strongly with, ambient air CO, and there is a weak correlation with ETCO, the results point to negligible endogenous airway CO production in healthy subjects. An EFR of around 120 ml s−1 can be recommended for clinical eCO measurements. The employed method provides means to measure variations in endogenous CO, which can improve the interpretation of exhaled CO concentrations and the diagnostic value of eCO tests in clinical studies. Clinical trial registration number: 2017/306-31
- Published
- 2020